Search Results 251-260 of 16385 for infliximab

  1. Carfilzomib (intravenous route) - Side effects & uses - Mayo Clinic

    Carfilzomib injection is used alone to treat relapsed (cancer that has come back) or refractory (cancer that did not respond to treatment) multiple myeloma (a ...

  2. Theophylline (intravenous route) - Side effects & uses - Mayo Clinic

    Infliximab; Isoniazid; Ketamine. Show More. Using this medicine with any of the following medicines may cause an increased risk of certain side effects, but ...

  3. Abatacept for the Treatment of Relapsing, Non-Severe, Granulomatosis With Polyangiitis (Wegener's) - Mayo Clinic

    Treatment with infliximab, etanercept, adalimumab, tocilizumab, or any other biologic agent within the past 3 months or 5 half lives of the agent (whichever is ...

  4. Breast cancer - Doctors and departments - Mayo Clinic

    Learn about this common cancer, including information on prevention, symptoms, diagnosis and treatment.

  5. Publications - Kristen B. McCullough, Pharm.D., R.Ph. - Mayo Clinic

    Safety and Efficacy of Infliximab Therapy in the Setting of Steroid-Refractory Acute Graft-versus-Host Disease. Biol Blood Marrow Transplant. 2017 Sep; 23 ...

  6. Breast cancer - Doctors and departments - Mayo Clinic

    Learn about this common cancer, including information on prevention, symptoms, diagnosis and treatment.

  7. Assessing Benefits And Harms Of Cannabis/Cannabinoid Use Among Cancer Patients Treated In Community Oncology Clinics

    * Participants with chronic or ongoing steroid or immunomodulatory agents (i.e., prednisone, dexamethasone, etanercept, infliximab, etc.). The use of ...

  8. Filgotinib in Long-Term Extension Study of Adults With Crohn's Disease - Mayo Clinic

    The primary objective of this study is to observe the long-term safety of filgotinib in adults who have completed or met protocol specified efficacy ...

  9. Myositis Interstitial Lung Disease Nintedanib Trial - Mayo Clinic

    Anti-tumor necrosis factor (infliximab, golimumab, or certolizumab) within 8 weeks or adalimumab within 4 weeks, and etanercept within 2 weeks of baseline.

  10. Aflibercept-yszy (intraocular route) - Side effects & uses - Mayo Clinic

    Aflibercept-yszy injection is used to treat neovascular (wet) age-related macular degeneration (AMD). AMD is a disorder of the retina in the eye that causes ...